Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R/R > TREAT.: > UK. A. BTK Inh. Tablets

---

UK. A. BTK Inh. Tablets's subsections
(*) USA Approval Date: 2022. 08.05
BTK: Bruton s Tyrosine Kinase
Company
Generic Name: Acalabrutinib
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2022. 08.02
RTM
RTM Web-Site

UK. A. BTK Inh. Tablets's products
This section has no products